Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer.

@article{Eloubeidi2008ImpactOS,
  title={Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer.},
  author={Mohamad Ali Eloubeidi and Renee L Desmond and Shilpa Desai and Mohit Mehra and Ayesha Bryant and Robert James Cerfolio},
  journal={Gastrointestinal endoscopy},
  year={2008},
  volume={67 2},
  pages={
          193-8
        }
}

• Mohamad Ali Eloubeidi, Renee L Desmond, +3 authors Robert James Cerfolio
• Published 2008 in Gastrointestinal endoscopy
• DOI:10.1016/j.gie.2007.06.052

BACKGROUND Transesophageal EUS-guided FNA (EUS-FNA) is safe, accurate, and cost effective in staging patients with non-small-cell lung cancer (NSCLC). However, the impact of EUS-FNA on patient survival has not been demonstrated. OBJECTIVE To determine the impact of metastatic disease in mediastinal lymph nodes as determined by EUS staging on treatment choice and survival in patients with NSCLC. DESIGN Retrospective analysis of prospectively collected data. SETTING Tertiary university… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed